Browse

Latest Headlines

Fresh headlines, crisp visuals — faster reading.

Accelerated Brain Stimulation: A New Hope for Relieving Depression?

Accelerated Brain Stimulation: A New Hope for Relieving Depression?

Research indicates that a condensed schedule of transcranial magnetic stimulation (TMS) treatments can effectively reduce depression symptoms. This form of therapy may especially benefit individuals with treatment-resistant depression, offering a shorter and potentially more accessible treatment option. Clinical Trial Insights A recent study found that TMS sessions could yield positive results in as few as five days by administering multiple sessions daily. Traditionally requiring weeks of daily visits, this "five-by-five" approach achieved comparable outcomes to conventional methods. The trial involved 40 patients receiving accelerated TMS and 135 undergoing standard treatment. Both groups experienced significant symptom reduction, but the accelerated method offered quicker relief for many participants. About Transcranial Magnetic Stimulation TMS is a non-invasive brain stimulation technique approved by the FDA for depression treatment. It uses magnetic pulses to activate specific brain regions without requiring surgery or sedation. Deep TMS (dTMS): Targets deeper brain areas. Repetitive TMS (rTMS): Involves repeated pulses over longer sessions. Theta-burst stimulation (TBS or iTBS): Employs quick bursts for short durations. Accelerated TMS (aTMS): Combines rapid pulses in condensed sessions across fewer days. Potential Candidates for TMS TMS may be suitable for individuals not responding to other depression treatments, but it is not recommended for those with metal implants in the head, certain medical conditions, or seizure histories. Barriers to Accessing TMS The therapy's benefits are sometimes limited by cost, insurance issues, stigma, provider availability, and time constraints. Accelerated protocols could ease some of these access challenges. The Takeaway An accelerated TMS regimen might offer faster relief and greater convenience for those with treatment-resistant depression. However, larger trials are necessary to validate these initial findings fully.

Mar 13, 2026